ヒトの表皮成長因子と受容体細胞外ドメインの複合体の結晶構造
Hideo Ogiso1, Ryuichiro Ishitani, Osamu Nureki
1RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi, 230-0045, Yokohama, Kanagawa, Japan.
Cell
|September 26, 2002
まとめ
皮質成長因子 (EGF) がその受容体 (EGFR) に結合すると,細胞の成長が誘発されます. この研究は,EGF-EGFR複合体の結晶構造を明らかにし,細胞シグナル伝達に不可欠なユニークな受容体二酸化機構を詳細に説明しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 構造生物学 構造生物学とは
背景:
- 皮膚表皮成長因子 (EGF) は,細胞増殖と分化の主な調節因子である.
- EGFは,受容体チロシンキナーゼである表皮成長因子受容体 (EGFR) の細胞外領域に結合することによってその機能を果たします.
- EGFRの活性化には,下流信号伝達の重要なステップである受容体の二分化が含まれています.
研究 の 目的:
- ヒトのEGFとEGFR細胞外領域複合体の結晶構造を決定する.
- EGF媒介によるEGFR二分化の分子メカニズムを解明する.
主な方法:
- X線結晶学を用いて,2. 2 EGF-EGFR複合体の構造を3. 3 Åの解像度で決定した.
- EGFRの突然変異は,観察された二分化界面を検証するために実施されました.
主要な成果:
- 結晶構造はEGFRドメインI-IIIのC形の配置を明らかにし,EGFはドメインIとドメインIIIの間にドッキングされている.
- 独特の"受容体媒介型二分化"メカニズムが特定され,一つのEGFR分子のドメインIIのベータヘアピンアームが,別のEGFR分子の体と相互作用する.
- EGFR突然変異は,この受容体受容体相互作用が二分化における重要な役割を果たしていることを確認しました.
結論:
- この研究は,EGF-EGFRの相互作用と二分化に関する高解像度構造的基礎を提供します.
- 特定された"受容体媒介型二分化"は,EGFR活性化に不可欠な新しいメカニズムです.
- これらの発見は,EGFRシグナル伝達経路の理解を深め,がんを標的とした治療戦略を導き出します.
関連する概念動画
Internal Receptors
57.4K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
57.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Integrins
4.8K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.8K
Anchoring Junctions
4.3K
Anchoring junctions are multiprotein complexes that help cells connect to other cells and the extracellular matrix. Anchoring junctions are present on the lateral and basal surfaces of cells, providing strong and flexible connections. Focal adhesions are often formed due to cell interactions with the ECM substrata, which initiate signal transduction via kinase cascades and other mechanisms. Together, they provide stability and tissue integrity. There are three types of anchoring junctions:...
4.3K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K


